LOBAR ATELECTASIS IN CYSTIC-FIBROSIS AND TREATMENT WITH RECOMBINANT HUMAN DNASE-I

被引：16
|
作者：
SHAH, PL [1 ]
SCOTT, SF [1 ]
HODSON, ME [1 ]
机构：
[1] ROYAL BROMPTON NATL HEART & LUNG INST,LONDON SW3 6NP,ENGLAND
来源：
RESPIRATORY MEDICINE | 1994年 / 88卷 / 04期
关键词：
D O I：
10.1016/0954-6111(94)90063-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：313 / 315
页数：3
相关论文
共 50 条
  • [21] In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis
    Shah, PL
    Scott, SF
    Knight, RA
    Marriott, C
    Ranasinha, C
    Hodson, ME
    THORAX, 1996, 51 (02) : 119 - 125
  • [22] DNA CONCENTRATION AND LENGTH IN SPUTUM OF PATIENTS WITH CYSTIC-FIBROSIS DURING INHALATION WITH RECOMBINANT HUMAN DNASE
    BRANDT, T
    BREITENSTEIN, S
    VONDERHARDT, H
    TUMMLER, B
    THORAX, 1995, 50 (08) : 880 - 882
  • [23] RECOMBINANT HUMAN DNASE-I IN CYSTIC-FIBROSIS PATIENTS WITH SEVERE PULMONARY-DISEASE - A SHORT-TERM, DOUBLE-BLIND-STUDY FOLLOWED BY 6 MONTHS OPEN-LABEL TREATMENT
    SHAH, PI
    BUSH, A
    CANNY, GJ
    COLIN, AA
    FUCHS, HJ
    GEDDES, DM
    JOHNSON, CAC
    LIGHT, MC
    SCOTT, SF
    TULLIS, DE
    DEVAULT, A
    WOHL, ME
    HODSON, ME
    EUROPEAN RESPIRATORY JOURNAL, 1995, 8 (06) : 954 - 958
  • [24] A PRELIMINARY-STUDY OF AEROSOLIZED RECOMBINANT HUMAN DEOXYRIBONUCLEASE-I IN THE TREATMENT OF CYSTIC-FIBROSIS
    HUBBARD, RC
    MCELVANEY, NG
    BIRRER, P
    SHAK, S
    ROBINSON, WW
    JOLLEY, C
    WU, M
    CHERNICK, MS
    CRYSTAL, RG
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (12): : 812 - 815
  • [25] RECOMBINANT HUMAN DNASE INHALATION IN NORMAL SUBJECTS AND PATIENTS WITH CYSTIC-FIBROSIS - A PHASE-1 STUDY
    AITKEN, ML
    BURKE, W
    MCDONALD, G
    SHAK, S
    MONTGOMERY, AB
    SMITH, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (14): : 1947 - 1951
  • [26] EFFECTS OF RECOMBINANT HUMAN DNASE THERAPY ON HEALTH-CARE USE AND COSTS IN PATIENTS WITH CYSTIC-FIBROSIS
    OSTER, G
    HUSE, DM
    LACEY, MJ
    REGAN, MM
    FUCHS, HJ
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (05) : 459 - 464
  • [27] Efficacy of human recombinant DNase in pediatric patients with cystic fibrosis
    Furuya, MEY
    Lezana-Fernández, JL
    Vargas, MH
    Hernández-Sierra, JF
    Ramírez-Figueroa, JL
    ARCHIVES OF MEDICAL RESEARCH, 2001, 32 (01) : 30 - 34
  • [28] Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?
    Conway, SP
    ARCHIVES OF DISEASE IN CHILDHOOD, 1997, 77 (01) : 1 - 3
  • [29] Engineering actin-resistant human DNase I for treatment of cystic fibrosis
    Ulmer, JS
    Herzka, A
    Toy, KJ
    Baker, DL
    Dodge, AH
    Sinicropi, D
    Shak, S
    Lazarus, RA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (16) : 8225 - 8229
  • [30] AEROSOL THERAPY IN CYSTIC-FIBROSIS - DNASE, TOBRAMYCIN
    MARSHALL, SG
    RAMSEY, BW
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 15 (05) : 434 - 438
12345